204 related articles for article (PubMed ID: 21195370)
21. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.
Sezaki H; Kobayashi M; Hosaka T; Someya T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Sato J; Kumada H
J Gastroenterol; 2004 Jun; 39(6):550-6. PubMed ID: 15235872
[TBL] [Abstract][Full Text] [Related]
22. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Ohata K; Hamasaki K; Toriyama K; Ishikawa H; Nakao K; Eguchi K
J Gastroenterol Hepatol; 2004 Jun; 19(6):670-5. PubMed ID: 15151623
[TBL] [Abstract][Full Text] [Related]
23. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
Romano PR; McCallus DE; Pachuk CJ
Oncogene; 2006 Jun; 25(27):3857-65. PubMed ID: 16799627
[TBL] [Abstract][Full Text] [Related]
24. [Hepatocellular carcinoma--epidemiology and treatment].
Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
[TBL] [Abstract][Full Text] [Related]
25. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation for hepatocellular carcinoma in Asia.
de Villa V; Lo CM
Oncologist; 2007 Nov; 12(11):1321-31. PubMed ID: 18055852
[TBL] [Abstract][Full Text] [Related]
27. [Liver transplantation for hepatocellular carcinoma].
Suh KS; Yi NJ
Korean J Hepatol; 2006 Dec; 12(4):493-506. PubMed ID: 17237627
[TBL] [Abstract][Full Text] [Related]
28. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
30. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
32. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
33. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
Kaczynski J
Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
Wen J; Shen WL; Yang SH
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
[TBL] [Abstract][Full Text] [Related]
35. Established and emerging therapies for hepatocellular carcinoma.
Cicinnati VR; Sotiropoulos GC; Beckebaum S
Minerva Med; 2010 Dec; 101(6):405-18. PubMed ID: 21196900
[TBL] [Abstract][Full Text] [Related]
36. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
Omata M; Ashcavai M; Liew CT; Peters RL
Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
39. Natural history of hepatocellular carcinoma and current treatment options.
Raoul JL
Semin Nucl Med; 2008 Mar; 38(2):S13-8. PubMed ID: 18243838
[TBL] [Abstract][Full Text] [Related]
40. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
